| 000 | 01778 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513233649.0 | ||
| 264 | 0 | _c20010816 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a1351-8216 | ||
| 024 | 7 |
_a10.1046/j.1365-2516.2001.00488.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrünewald, M | |
| 245 | 0 | 0 |
_aAcquired haemophilia: experiences with a standardized approach. _h[electronic resource] |
| 260 |
_bHaemophilia : the official journal of the World Federation of Hemophilia _cMar 2001 |
||
| 300 |
_a164-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcute-Phase Reaction _xcomplications |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBlood Coagulation Factors _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDiagnosis, Computer-Assisted |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aDrug Therapy, Computer-Assisted _xmethods |
| 650 | 0 | 4 |
_aFactor VII _xadministration & dosage |
| 650 | 0 | 4 |
_aFactor VIII _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemophilia A _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aIsoantibodies _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisolone _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 700 | 1 | _aBeneke, H | |
| 700 | 1 | _aGüthner, C | |
| 700 | 1 | _aGermowitz, A | |
| 700 | 1 | _aBrommer, A | |
| 700 | 1 | _aGriesshammer, M | |
| 773 | 0 |
_tHaemophilia : the official journal of the World Federation of Hemophilia _gvol. 7 _gno. 2 _gp. 164-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2516.2001.00488.x _zAvailable from publisher's website |
| 999 |
_c11196780 _d11196780 |
||